Intestinal schistosomiasis in mothers and young children in Uganda: Investigation of field-applicable markers of bowel morbidity

American Journal of Tropical Medicine and Hygiene

Volumn 83, Issue 5, 2010, Pages 1048-1055

  Betson, Martha ^a   Sousa Figueiredo, Jose Carlos ^a,b   Rowell, Candia ^c   Kabatereine, Narcis B ^c   Stothard, J Russell ^a  

^a DEPARTMENT OF LIFE SCIENCES   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c MINISTRY OF HEALTH   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; CALGRANULIN; MARKER; PRAZIQUANTEL; ANTHELMINTIC AGENT;

ADOLESCENT; ADULT; AFRICA; AGED; ARTICLE; ASSOCIATION; CHILD; COHORT ANALYSIS; DISEASE ASSOCIATION; FECES ANALYSIS; FEMALE; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; INTESTINE; INTESTINE INFECTION; MAJOR CLINICAL STUDY; MORBIDITY; MOTHER; NONHUMAN; OCCULT BLOOD; PREVALENCE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SCHISTOSOMIASIS MANSONI; UGANDA; CHEMISTRY; FECES; INFANT; MIDDLE AGED; PRESCHOOL CHILD; RISK;

SCHISTOSOMA MANSONI;

ADOLESCENT; ADULT; AGED; ALBENDAZOLE; ANTHELMINTICS; CHILD; CHILD, PRESCHOOL; FECES; FEMALE; HUMANS; INFANT; LEUKOCYTE L1 ANTIGEN COMPLEX; MIDDLE AGED; MORBIDITY; OCCULT BLOOD; ODDS RATIO; PRAZIQUANTEL; PREVALENCE; SCHISTOSOMIASIS MANSONI; UGANDA; YOUNG ADULT;

EID: 79951558220     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2010.10-0307     Document Type: Article

References (47)

1. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J, 2006. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6: 411-425. (Pubitemid 43949139)
2. Gryseels B, Polman K, Clerinx J, Kestens L, 2006. Human schistosomiasis. Lancet 368: 1106-1118. (Pubitemid 44402679)
3. van der Werf MJ, de Vlas SJ, Brooker S, Looman CW, Nagelkerke NJ, Habbema JD, Engels D, 2003. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 86: 125-139. (Pubitemid 36561364)
4. Ongom VL, Owor R, Grundy R, Bradley DJ, 1972. The epidemiology and consequences of Schistosoma mansoni infection in West Nile, Uganda. II. Hospital investigation of a sample from the Panyagoro community. Trans R Soc Trop Med Hyg 66: 852-863.
5. Owor R, 1971. Pathological aspects of schistosomiasis in Uganda with particular reference to West Nile. East Afr Med J 48: 399-405.
6. von Lichtenberg F, 1987. Consequences of infections with schistosomes. Rollinson D, Simpson AJG, eds. The Biology of Schistosomes. From Genes to Latrines. London: Academic Press Ltd., 185-232.
7. Montes M, White AC Jr, Kontoyiannis DP, 2004. Symptoms of intestinal schistosomiasis presenting during treatment of large B cell lymphoma. Am J Trop Med Hyg 71: 552-553. (Pubitemid 39601149)
8. Nelson GS, 1958. Schistosoma mansoni infection in the West Nile District of Uganda. IV. Anaemia and S. mansoni infection. East Afr Med J 35: 581-586.
9. Owor R, Madda JP, 1977. Schistosomiasis causing tumour-like lesions. East Afr Med J 54: 137-141.
10. Ongom VL, Bradley DJ, 1972. The epidemiology and consequences of Schistosoma mansoni infection in West Nile, Uganda. I. Field studies of a community at Panyagoro. Trans R Soc Trop Med Hyg 66: 835-851.
11. King CH, Dickman K, Tisch DJ, 2005. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365: 1561-1569. (Pubitemid 40615405)
12. Lamyman MJ, Noble DJ, Narang S, Dehalvi N, 2006. Small bowel obstruction secondary to intestinal schistosomiasis. Trans R Soc Trop Med Hyg 100: 885-887. (Pubitemid 43986281)
13. Pearce EJ, MacDonald AS, 2002. The immunobiology of schistosomiasis. Nat Rev Immunol 2: 499-511. (Pubitemid 37328741)
14. Lambertucci JR, dos Santos Silva LC, Andrade LM, de Queiroz LC, Carvalho VT, Voieta I, Antunes CM, 2008. Imaging techniques in the evaluation of morbidity in schistosomiasis mansoni. Acta Trop 108: 209-217.
15. Vennervald BJ, Dunne DW, 2004. Morbidity in schistosomiasis: an update. Curr Opin Infect Dis 17: 439-447. (Pubitemid 39407375)
16. Fenwick A, Webster JP, Bosque-Oliva E, Blair L, Fleming FM, Zhang Y, Garba A, Stothard JR, Gabrielli AF, Clements AC, Kabatereine NB, Toure S, Dembele R, Nyandindi U, Mwansa J, Koukounari A, 2009. The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008. Parasitology 136: 1719-1730.
17. Bundy DA, Shaeffer S, Jukes M, Beegle K, Gillespie A, Drake L, Lee SF, Hoffman AM, Jones J, Mitchell A, Wright C, Barcelona D, Camara B, Golmar C, Savioli L, Takeuchi T, Sembene M, 2005. School-based health and nutrition programs. Breman JG, Meacham AR, Alleyne G, Claeson M, Evans D, Jha P, Mills A, Musgrove P, eds. Disease Control Priorities in Developing Countries. Oxford, United Kingdom: Oxford University Press, 1091-1108.
18. Stothard JR, Gabrielli AF, 2007. Schistosomiasis in African infants and preschool children: to treat or not to treat? Trends Parasitol 23: 83-86. (Pubitemid 46274503)
19. Sousa-Figueiredo JC, Pleasant J, Day M, Betson M, Rollinson D, Montresor A, Kazibwe F, Kabatereine NB, Stothard JR, 2010. Treatment of intestinal schistosomiasis in Ugandan preschool children: best diagnosis, treatment efficacy and side-effects, and an extended praziquantel dosing pole. Int Health 2: 103-113.
20. Webster JP, Koukounari A, Lamberton PH, Stothard JR, Fenwick A, 2009. Evaluation and application of potential schistosome-associated morbidity markers within large-scale mass chemotherapy programmes. Parasitology 136: 1789-1799.
21. Lengeler C, Utzinger J, Tanner M, 2002. Questionnaires for rapid screening of schistosomiasis in sub-Saharan Africa. Bull World Health Organ 80: 235-242. (Pubitemid 34285736)
22. Reimert CM, Tukahebwa EM, Kabatereine NB, Dunne DW, Vennervald BJ, 2008. Assessment of Schistosoma mansoni induced intestinal inflammation by means of eosinophil cationic protein, eosinophil protein X and myeloperoxidase before and after treatment with praziquantel. Acta Trop 105: 253-259.
23. Kerkhoff C, Klempt M, Sorg C, 1998. Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Biochim Biophys Acta 1448: 200-211. (Pubitemid 29052193)
24. Foell D, Wittkowski H, Roth J, 2009. Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage. Gut 58: 859-868.
25. Gisbert JP, McNicholl AG, 2009. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Dig Liver Dis 41: 56-66.
26. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L, 2008. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 103: 1541-1549. (Pubitemid 351813919)
27. Lehman JS Jr, Mott KE, Morrow RH Jr, Muniz TM, Boyer MH, 1976. The intensity and effects of infection with Schistosoma mansoni in a rural community in northeast Brazil. Am J Trop Med Hyg 25: 285-294.
28. Kanzaria HK, Acosta LP, Langdon GC, Manalo DL, Olveda RM, McGarvey ST, Kurtis JD, Friedman JF, 2005. Schistosoma japonicum and occult blood loss in endemic villages in Leyte, the Philippines. Am J Trop Med Hyg 72: 115-118. (Pubitemid 41278891)
29. Katz N, Chaves A, Pellegrino J, 1972. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 14: 397-400.
30. Montresor A, Crompton DW, Hall A, Bundy DA, Savioli L, 1998. Guidelines for the Evaluation of Soil-Transmitted Helminthiasis and Schistosomiasis at the Community Level. A Guide for Managers of Control Programmes. Geneva: World Health Organization.
31. Kirkwood BR, Sterne JA, 2003. Essential Medical Statistics. Oxford, UK: Blackwell Science.
32. Fisher RA, 1922. On the interpretation of chi-square from contingency tables and the calculation of P. JR Stat Soc 85: 87-94.
33. Ansell J, Guyatt HL, 2002. Comparative cost-effectiveness of diagnostic tests for urinary schistosomiasis and the implications for school health programmes. Ann Trop Med Parasitol 96: 145-153. (Pubitemid 34298949)
34. Raso G, Luginbuhl A, Adjoua CA, Tian-Bi NT, Silue KD, Matthys B, Vounatsou P, Wang Y, Dumas ME, Holmes E, Singer BH, Tanner M, N'Goran EK, Utzinger J, 2004. Multiple parasite infections and their relationship to self-reported morbidity in a community of rural Cote d'Ivoire. Int J Epidemiol 33: 1092-1102. (Pubitemid 39430005)
35. Rudge JW, Stothard JR, Basanez MG, Mgeni AF, Khamis IS, Khamis AN, Rollinson D, 2008. Micro-epidemiology of urinary schistosomiasis in Zanzibar: local risk factors associated with distribution of infections among schoolchildren and relevance for control. Acta Trop 105: 45-54. (Pubitemid 350256725)
36. Yang TH, Tzeng S, Cheng I, Burnett MG, Yoshizawa Y, Fukuyama K, Lee SC, Epstein WL, 1997. Identification of the mouse calcium-binding proteins, MRP 8 and MRP 14, in Schistosoma mansoni-induced granulomas: biochemical and functional characterization. J Leukoc Biol 61: 258-266. (Pubitemid 27149904)
37. Jeffery J, Joshi S, Lewis SJ, Creanor S, Ayling RM, 2009. Age-related faecal calprotectin, lactoferrin, and tumour M2-PK concentrations in healthy volunteers. Ann Clin Biochem 47: 259-263.
38. Campeotto F, Butel MJ, Kalach N, Derrieux S, Aubert-Jacquin C, Barbot L, Francoual C, Dupont C, Kapel N, 2004. High faecal calprotectin concentrations in newborn infants. Arch Dis Child Fetal Neonatal Ed 89: F353-F355. (Pubitemid 38869681)
39. Savino F, Castagno E, Calabrese R, Viola S, Oggero R, Miniero R, 2009. High faecal calprotectin levels in healthy, exclusively breast-fed infants. Neonatology 97: 299-304.
40. Damms A, Bischoff SC, 2008. Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases. Int J Colorectal Dis 23: 985-992.
41. Shastri Y, Povse N, Stein J, 2009. A prospective comparative study for new rapid bedside fecal calprotectin test with an established ELISA to assess intestinal inflammation. Clin Lab 55: 53-55.
42. Stothard JR, Pleasant J, Oguttu D, Adriko M, Galimaka R, Ruggiana A, Kazibwe F, Kabatereine NB, 2008. Strongyloides stercoralis: a field-based survey of mothers and their preschool children using ELISA, Baermann and Koga plate methods reveals low endemicity in western Uganda. J Helminthol 82: 263-269.
43. Sousa-Figueiredo JC, Basanez MG, Mgeni AF, Khamis IS, Rollinson D, Stothard JR, 2008. A parasitological survey, in rural Zanzibar, of pre-school children and their mothers for urinary schistosomiasis, soil-transmitted helminthiases and malaria, with observations on the prevalence of anaemia. Ann Trop Med Parasitol 102: 679-692. (Pubitemid 352774014)
44. Stothard JR, Webster BL, Weber T, Nyakaana S, Webster JP, Kazibwe F, Kabatereine NB, Rollinson D, 2009. Molecular epidemiology of Schistosoma mansoni in Uganda: DNA barcoding reveals substantial genetic diversity within Lake Albert and Lake Victoria populations. Parasitology 136: 1813-1824.
45. Warren KS, Su DL, Xu ZY, Yuan HC, Peters PA, Cook JA, Mott KE, Houser HB, 1983. Morbidity in schistosomiasis japonica in relation to intensity of infection. A study of two rural brigades in Anhui Province, China. N Engl J Med 309: 1533-1539. (Pubitemid 14212834)
46. Ndamba J, Makaza N, Kaondera KC, Munjoma M, 1991. Morbidity due to Schistosoma mansoni among sugar-cane cutters in Zimbabwe. Int J Epidemiol 20: 787-795.
47. Armitage P, Berry G, 1994. Statistical Methods in Medical Research. Oxford, UK: Blackwell Scientific.